FDA okays GMO carrot for rare Gaucher disease

The US Food & Drug Admin. just approved a drug made from genetically modified carrots to treat Gaucher, a rare disease found mostly among Ashkenazi Jews. Out of a global population of 6.8 billion, an estimated 600,000 to a million people carry the recessive gene for it, though not all are symptomatic.

View the original article here: FDA okays GMO carrot for rare Gaucher disease

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend